Segmentation of key figures (Details 4) - Accumulated depreciation, amortisation and impairment - USD ($)
$ in Millions |
3 Months Ended |
6 Months Ended |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
| Intangible Assets other than Goodwill |
|
|
|
|
| Disclosure of detailed information about intangible assets [line items] |
|
|
|
|
| Impairment charge |
$ (500)
|
$ (22)
|
$ (551)
|
$ (478)
|
| Spinifex | Acquired research and development [member] |
|
|
|
|
| Disclosure of detailed information about intangible assets [line items] |
|
|
|
|
| Impairment charge |
|
|
|
(416)
|
| ZPL389 [member] | Acquired research and development [member] |
|
|
|
|
| Disclosure of detailed information about intangible assets [line items] |
|
|
|
|
| Impairment charge |
(485)
|
|
(485)
|
|
| Innovative Medicines | Intangible Assets other than Goodwill |
|
|
|
|
| Disclosure of detailed information about intangible assets [line items] |
|
|
|
|
| Impairment charge |
(500)
|
(20)
|
(509)
|
(466)
|
| Sandoz | Intangible Assets other than Goodwill |
|
|
|
|
| Disclosure of detailed information about intangible assets [line items] |
|
|
|
|
| Impairment charge |
$ 0
|
$ (2)
|
$ (42)
|
$ (12)
|